Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Recent advances in the genetics of amyotrophic lateral sclerosis (ALS) have provided key mechanistic insights to the pathogenesis of this devastating neurodegenerative disease. Among many etiologies for ALS, the identification of mutations and proteinopathies in two RNA binding proteins, TDP-43 (TARDBP or TAR DNA binding protein 43) and its closely related RNA/DNA binding protein FUS (fused in sarcoma), raises the intriguing possibility that perturbations to the RNA homeostasis and metabolism in neurons may contribute to the pathogenesis of these diseases. Although the similarities between TDP-43 and FUS suggest that mutations and proteinopathy involving these two proteins may converge on the same mechanisms leading to neurodegeneration, there is increasing evidence that FUS mutations target distinct mechanisms to cause early disease onset and aggressive progression of disease. This review focuses on the recent advances on the molecular, cellular and genetic approaches to uncover the mechanisms of wild type and mutant FUS proteins during development and in neurodegeneration. These findings provide important insights to understand how FUS mutations may perturb the maintenance of dendrites through fundamental processes in RNA splicing, RNA transport and DNA damage response/repair. These results contribute to the understanding of phenotypic manifestations in neurodegeneration related to FUS mutations, and to identify important directions for future investigations. This article is part of a Special Issue entitled SI:RNA Metabolism in Disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576 · cited 2×
“Under physiological conditions, TDP-43 6 is a ubiquitous nuclear protein, however, in FTD patients, TDP-43 aggregates are present predominantly in neuronal cytoplasm and dystrophic neuronal processes (Arai et al., 2006; Neumann et al., 2006).”
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092 · cited 1×
“Mutations in DNA repair machinery have been linked to hereditary neurodegenerative diseases (Jackson and Bartek, 2009; McKinnon, 2009; Rass et al., 2007).”
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409 · cited 1×
“Finally, in 2011 two groups independently reported the GGGGCC hexanucleotide repeat expansions in the noncoding region of the C9ORF72 gene as causal links to ALS and FTD (DeJesusHernandez et al., 2011; Renton et al., 2011).”
Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
The Spliceosome: Design Principles of a Dynamic RNP Machine
Wahl, M. C., Will, C. L., & Lührmann, R. (2009) · Cell · doi:10.1016/j.cell.2009.02.009 · Cited by 2,665
Kato, M., Han, T. W., Xie, S., Shi, K., Du, X., Wu, L. C., Mirzaei, H., Goldsmith, E. J., Longgood, J., Pei, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.017 · Cited by 2,012 · cited 2×
“…its role in the formation of RNA granules comes from the observation of a small molecule chemical 5-aryl-isoxazole-3-carboxyamide, which when biotinylated acquires the unique property to aggregate and disaggregate RNA granules in a soluble, cell-free system (Han et al., 2012; Kato et al., 2012).”
Gene regulation and DNA damage in the ageing human brain
Lu, T., Pan, Y., Kao, S.-Y., Li, C., Kohane, I., Chan, J., & Yankner, B. A. (2004) · Nature · doi:10.1038/nature02661 · Cited by 1,874
Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis
Ling, S.-C., Polymenidou, M., & Cleveland, D. W. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.033 · Cited by 1,811 · cited 1×
“…dismutase 1 (SOD1), two genes encoding RNA/DNA binding proteins, TDP43 (TARDBP or TAR-DNA-binding protein-43) and FUS/TLS (fused in sarcoma/translocation in liposarcoma or FUS), and the GGGGCC hexanucleotide expansions in C9ORF72 gene (Cirulli et al., 2015; Lee et al., 2012; Ling et al., 2013).”
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623
Bender, A., Krishnan, K. J., Morris, C. M., Taylor, G. A., Reeve, A. K., Perry, R. H., Jaros, E., Hersheson, J. S., Betts, J., Klopstock, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1769 · Cited by 1,570 · cited 1×
“In addition to the inherited forms of neurodegenerative diseases, DNA damage and genomic instability have also been linked to late-onset neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease (Anderson et al., 1996; Bender et al., 2006; Lu et al., 2004).”
Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43
Polymenidou, M., Lagier-Tourenne, C., Hutt, K. R., Huelga, S. C., Moran, J., Liang, T. Y., Ling, S.-C., Sun, E., Wancewicz, E., Mazur, C., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2779 · Cited by 1,335
mRNA localization: Gene expression in the spatial dimension
Martin, K. C., & Ephrussi, A. (2009) · Cell · doi:10.1016/j.cell.2009.01.044 · Cited by 1,048 · cited 1×
“In the nervous system, these regulatory mechanisms are known to generate a vast diversity of RNA transcripts that control cell fate determination, axon guidance, dendritic growth and synaptic functions (Li et al., 2007; Martin and Ephrussi, 2009).”
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
Cirulli, E. T., Lasseigne, B. N., Petrovski, S., Sapp, P. C., Dion, P. A., Leblond, C. S., Couthouis, J., Lu, Y.-F., Wang, Q., Krueger, B. J., et al. (2015) · Science · doi:10.1126/science.aaa3650 · Cited by 966 · cited 2×
“Early Disease Onset in FALS Caused by FUS Mutations 7 It is estimated that mutations in TARDBP and FUS each account for ~5% of FALS, whereas the GGGGCC expansion mutations in C9ORF72 account for 20-40% of ALS and FTD-ALS cases, depending on the population studied (Cirulli et al., 2015).”
An epigenetic blockade of cognitive functions in the neurodegenerating brain
Gräff, J., Rei, D., Guan, J.-S., Wang, W.-Y., Seo, J., Hennig, K. M., Nieland, T. J. F., Fass, D. M., Kao, P. F., Kahn, M., et al. (2012) · Nature · doi:10.1038/nature10849 · Cited by 853
ALS‐associated fused in sarcoma (FUS) mutations disrupt Transportin‐mediated nuclear import
Dormann, D., Rodde, R., Edbauer, D., Bentmann, E., Fischer, I., Hruscha, A., Than, M. E., Mackenzie, I. R. A., Capell, A., Schmid, B., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.143 · Cited by 836
Axonal Transport of TDP-43 mRNA Granules Is Impaired by ALS-Causing Mutations
Alami, N. H., Smith, R. B., Carrasco, M. A., Williams, L. A., Winborn, C. S., Han, S. S. W., Kiskinis, E., Winborn, B., Freibaum, B. D., Kanagaraj, A., et al. (2014) · Neuron · doi:10.1016/j.neuron.2013.12.018 · Cited by 660
Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration
Lee, E. B., Lee, V. M.-Y., & Trojanowski, J. Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3121 · Cited by 659 · cited 1×
“…dismutase 1 (SOD1), two genes encoding RNA/DNA binding proteins, TDP43 (TARDBP or TAR-DNA-binding protein-43) and FUS/TLS (fused in sarcoma/translocation in liposarcoma or FUS), and the GGGGCC hexanucleotide expansions in C9ORF72 gene (Cirulli et al., 2015; Lee et al., 2012; Ling et al., 2013).”
Lukas, J., Lukas, C., & Bartek, J. (2011) · Nature Cell Biology · doi:10.1038/ncb2344 · Cited by 645 · cited 1×
“…persistent phenotypes related to DNA repair defects, including dysregulation of histone acetylation, abnormalities in heterochromatin formation, and aberrant expansion and recondensing of the chromatin structure in DNA repair process (Dinant et al., 2008; Lukas et al., 2011; Miller et al., 2010).”
Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining
Miller, K. M., Tjeertes, J. V., Coates, J., Legube, G., Polo, S. E., Britton, S., & Jackson, S. P. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1899 · Cited by 629 · cited 1×
“…persistent phenotypes related to DNA repair defects, including dysregulation of histone acetylation, abnormalities in heterochromatin formation, and aberrant expansion and recondensing of the chromatin structure in DNA repair process (Dinant et al., 2008; Lukas et al., 2011; Miller et al., 2010).”
Ribosome stalling induced by mutation of a CNS-specific tRNA causes neurodegeneration
Ishimura, R., Nagy, G., Dotu, I., Zhou, H., Yang, X.-L., Schimmel, P., Senju, S., Nishimura, Y., Chuang, J. H., & Ackerman, S. L. (2014) · Science · doi:10.1126/science.1249749 · Cited by 455 · cited 1×
“Since GTPBP2 is an essential binding partner for the ribosome recycling protein pelota, loss of GTPBP2 results in widespread ribosomal stalling and profound age-dependent neurodegeneration in the cerebellum of nmf205 mutants (Ishimura et al., 2014).”
Disorders of nucleotide excision repair: the genetic and molecular basis of heterogeneity
Cleaver, J. E., Lam, E. T., & Revet, I. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2663 · Cited by 428 · cited 2×
“…as excision repair cross-complementing rodent repair deficiency, complementation group 6 or ERCC6), CSB (ERCC8), XPD (ERCC2) and XPG (ERCC5), develop Cockyane syndrome, characterized by retinal degeneration, microcephaly, deafness and loss of Purkinje cells in the cerebellum (Cleaver et al., 2009).”
A Conserved mRNA Export Machinery Coupled to pre-mRNA Splicing
Reed, R., & Hurt, E. (2002) · Cell · doi:10.1016/s0092-8674(02)00627-x · Cited by 400
Neuronal regulation of alternative pre-mRNA splicing
Li, Q., Lee, J.-A., & Black, D. L. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2237 · Cited by 376 · cited 1×
“In the nervous system, these regulatory mechanisms are known to generate a vast diversity of RNA transcripts that control cell fate determination, axon guidance, dendritic growth and synaptic functions (Li et al., 2007; Martin and Ephrussi, 2009).”
Defective DNA Repair and Neurodegenerative Disease
Rass, U., Ahel, I., & West, S. C. (2007) · Cell · doi:10.1016/j.cell.2007.08.043 · Cited by 358 · cited 1×
“Mutations in DNA repair machinery have been linked to hereditary neurodegenerative diseases (Jackson and Bartek, 2009; McKinnon, 2009; Rass et al., 2007).”
TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling
Zinszner, H., Sok, J., Immanuel, D., Yin, Y., & Ron, D. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.15.1741 · Cited by 350
RNA targets of wild-type and mutant FET family proteins
Hoell, J. I., Larsson, E., Runge, S., Nusbaum, J. D., Duggimpudi, S., Farazi, T. A., Hafner, M., Borkhardt, A., Sander, C., & Tuschl, T. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2163 · Cited by 350
Arginine methylation next to the PY‐NLS modulates Transportin binding and nuclear import of FUS
Dormann, D., Madl, T., Valori, C. F., Bentmann, E., Tahirovic, S., Abou‐Ajram, C., Kremmer, E., Ansorge, O., Mackenzie, I. R. A., Neumann, M., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.261 · Cited by 326 · cited 1×
“…interrupted by a Cys2-Cys2 zinc-finger motif (ZNF)(amino acids 422-453), and a non-conventional nuclear localization signal (NLS)(amino acids 510-526), which interacts with the nuclear transport receptor Transportin 1 (Figure 2)(Dormann et al., 2012; Dormann et al., 2010; Iko et al., 2004).”
DNA repair deficiency and neurological disease
McKinnon, P. J. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2559 · Cited by 323 · cited 1×
“Mutations in DNA repair machinery have been linked to hereditary neurodegenerative diseases (Jackson and Bartek, 2009; McKinnon, 2009; Rass et al., 2007).”
Hicks, G. G., Singh, N., Nashabi, A., Mai, S., Bozek, G., Klewes, L., Arapovic, D., White, E. K., Koury, M. J., Oltz, E. M., et al. (2000) · Nature Genetics · doi:10.1038/72842 · Cited by 299 · cited 4×
“Consequently, FUS–/– mice present with increased numbers of unpaired and mispaired chromosomal axes in pre-meiotic spermatocytes and in B lymphocytes (Hicks et al., 2000; Kuroda et al., 2000).”
InfluentialDeregulation of HDAC1 by p25/Cdk5 in Neurotoxicity
Kim, D., Frank, C. L., Dobbin, M. M., Tsunemoto, R. K., Tu, W., Peng, P. L., Guan, J.-S., Lee, B.-H., Moy, L. Y., Giusti, P., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.015 · Cited by 286
Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain
Rogelj, B., Easton, L. E., Bogu, G. K., Stanton, L. W., Rot, G., Curk, T., Zupan, B., Sugimoto, Y., Modic, M., Haberman, N., et al. (2012) · Scientific Reports · doi:10.1038/srep00603 · Cited by 278 · cited 2×
“Perhaps the most unique feature is that in genes with long intron, FUS-RNA binding exhibits a distinct “sawtooth” CLIP pattern (LagierTourenne et al., 2012; Rogelj et al., 2012), with substantially higher FUS cluster density at the beginning of introns and a gradual decrease toward the 3’ sequence.”
SIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons
Dobbin, M. M., Madabhushi, R., Pan, L., Chen, Y., Kim, D., Gao, J., Ahanonu, B., Pao, P.-C., Qiu, Y., Zhao, Y., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3460 · Cited by 250
The neuropathology associated with repeat expansions in the C9ORF72 gene
Mackenzie, I. R. A., Frick, P., & Neumann, M. (2014) · Acta Neuropathologica · doi:10.1007/s00401-013-1232-4 · Cited by 206 · cited 1×
“…can be detected in FTD and ALS patients with C9ORF72 mutations, the neuropathological features in these cases are quite heterogeneous and also include prominent ubiquitin and p62 positive, but TDP-43 negative intracytoplasmic and intranuclear inclusions (Bigio, 2012; Mackenzie et al., 2014).”
Identification and characterization of FUS/TLS as a new target of ATM
Gardiner, M., Toth, R., Vandermoere, F., Morrice, N. A., & Rouse, J. (2008) · Biochemical Journal · doi:10.1042/bj20081135 · Cited by 111 · cited 1×
“Interestingly, wild type FUS, but not FUS-CHOP fusion protein can be phosphorylated by ATM (ataxia-telangiectasia mutated) in response to DNA double strand breaks (DSBs)(Gardiner et al., 2008).”
Cited by
Decoding ALS: from genes to mechanism
Taylor, J. P., Brown, R. H., & Cleveland, D. W. (2016) · Nature · doi:10.1038/nature20413 · Cited by 2,066
RNA buffers the phase separation behavior of prion-like RNA binding proteins
Maharana, S., Wang, J., Papadopoulos, D. K., Richter, D., Pozniakovsky, A., Poser, I., Bickle, M., Rizk, S., Guillén-Boixet, J., Franzmann, T. M., et al. (2018) · Science · doi:10.1126/science.aar7366 · Cited by 1,106
ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?
Mejzini, R., Flynn, L. L., Pitout, I. L., Fletcher, S., Wilton, S. D., & Akkari, P. A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01310 · Cited by 755
Comprehensive Identification of RNA-Binding Domains in Human Cells
Castello, A., Fischer, B., Frese, C. K., Horos, R., Alleaume, A.-M., Foehr, S., Curk, T., Krijgsveld, J., & Hentze, M. W. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.06.029 · Cited by 637
FUS affects circular RNA expression in murine embryonic stem cell-derived motor neurons
Errichelli, L., Dini Modigliani, S., Laneve, P., Colantoni, A., Legnini, I., Capauto, D., Rosa, A., De Santis, R., Scarfò, R., Peruzzi, G., et al. (2017) · Nature Communications · doi:10.1038/ncomms14741 · Cited by 541
Metadata
- Authors
- Shang, Y., & Huang, E. J.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2016-09
- Volume
- 1647
- Pages
- 65-78
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W2319802474
- Cited by
- 154
- References
- 35
- FWCI
- 10.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.